BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28763482)

  • 21. Neuropsychological Alterations in Narcolepsy with Cataplexy and the Expression of Cognitive Deficits.
    Medrano-Martinez P; Peraita-Adrados R
    J Int Neuropsychol Soc; 2020 Jul; 26(6):587-595. PubMed ID: 31826783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.
    Bassetti CLA; Adamantidis A; Burdakov D; Han F; Gay S; Kallweit U; Khatami R; Koning F; Kornum BR; Lammers GJ; Liblau RS; Luppi PH; Mayer G; Pollmächer T; Sakurai T; Sallusto F; Scammell TE; Tafti M; Dauvilliers Y
    Nat Rev Neurol; 2019 Sep; 15(9):519-539. PubMed ID: 31324898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ullanlinna Narcolepsy Scale in diagnosis of narcolepsy.
    Sarkanen T; Alakuijala A; Partinen M
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30476331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives.
    Juvodden HT; Alnæs D; Lund MJ; Agartz I; Andreassen OA; Dietrichs E; Thorsby PM; Westlye LT; Knudsen S
    Sleep; 2018 Oct; 41(10):. PubMed ID: 30016530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remitting narcolepsy? Longitudinal observations in a hypocretin-deficient cohort.
    Büchele F; Baumann CR; Poryazova R; Werth E; Valko PO
    Sleep; 2018 Sep; 41(9):. PubMed ID: 29868885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attentional impairment in children with attention deficit and hyperactivity disorder].
    Abbes Z; Bouden A; Amado I; Chantal Bourdel M; Tabbane K; Béchir Halayem M
    Tunis Med; 2009 Oct; 87(10):645-50. PubMed ID: 20187350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective deficits of attention, cognition and depression in patients with narcolepsy.
    Zamarian L; Högl B; Delazer M; Hingerl K; Gabelia D; Mitterling T; Brandauer E; Frauscher B
    Sleep Med; 2015 Jan; 16(1):45-51. PubMed ID: 25434299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
    Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
    CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study.
    Romigi A; Bari M; Liguori C; Izzi F; Rapino C; Nuccetelli M; Battista N; Bernardini S; Centonze D; Mercuri NB; Placidi F; Maccarrone M
    CNS Neurol Disord Drug Targets; 2020; 19(2):142-147. PubMed ID: 32148204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis.
    Barateau L; Lopez R; Chenini S; Pesenti C; Rassu AL; Jaussent I; Dauvilliers Y
    Neurology; 2020 Nov; 95(20):e2755-e2768. PubMed ID: 32963102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Attentional Networks in fetal alcohol spectrum disorder and the inattentive and combined subtypes of attention deficit hyperactivity disorder.
    Kooistra L; Crawford S; Gibbard B; Kaplan BJ; Fan J
    Dev Neuropsychol; 2011; 36(5):566-77. PubMed ID: 21667361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D deficiency in type 1 narcolepsy: a reappraisal.
    Dauvilliers Y; Evangelista E; Lopez R; Barateau L; Scholz S; Crastes de Paulet B; Carlander B; Jaussent I
    Sleep Med; 2017 Jan; 29():1-6. PubMed ID: 28153207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered reinforcement learning in Narcolepsy type I and other central disorders of hypersomnolence.
    Strauss M; Griffon L; Elbaz M; Arnulf I; Chennaoui M; Léger D
    Sleep Med; 2024 Jan; 113():103-110. PubMed ID: 37995471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations.
    Gool JK; Zhang Z; Fronczek R; Amesz P; Khatami R; Lammers GJ
    Sleep Med; 2024 Apr; 116():105-114. PubMed ID: 38442518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical autonomic dysfunction in narcolepsy type 1.
    Barateau L; Chenini S; Evangelista E; Jaussent I; Lopez R; Dauvilliers Y
    Sleep; 2019 Dec; 42(12):. PubMed ID: 31418025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep spindle density in narcolepsy.
    Christensen JAE; Nikolic M; Hvidtfelt M; Kornum BR; Jennum P
    Sleep Med; 2017 Jun; 34():40-49. PubMed ID: 28522097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired conflict resolution and alerting in children with ADHD: evidence from the Attention Network Task (ANT).
    Johnson KA; Robertson IH; Barry E; Mulligan A; Dáibhis A; Daly M; Watchorn A; Gill M; Bellgrove MA
    J Child Psychol Psychiatry; 2008 Dec; 49(12):1339-47. PubMed ID: 19120713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-the-road driving performance of patients with central disorders of hypersomnolence.
    van der Sluiszen NNJJM; Urbanus B; Lammers GJ; Overeem S; Ramaekers JG; Vermeeren A
    Traffic Inj Prev; 2021; 22(2):120-126. PubMed ID: 33543997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the emotional and behavioural profile in paediatric narcolepsy type 1: A case-control study.
    Simoncini Malucelli G; Mercante A; Pizza F; Brunetti V; Biscarini F; Vandi S; Mazzoni A; Franceschini C; Della Marca G; Vollono C; Chieffo DPR; Plazzi G
    J Sleep Res; 2023 Oct; ():e14064. PubMed ID: 37872846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.